ENGLEWOOD CLIFFS, NJ, April 19, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq:SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics ...
MALVERN, PA / ACCESSWIRE / January 14, 2020 / Virpax ® Pharmaceuticals Inc. ("Virpax"), a company specializing in developing pharmaceutical products for pain management by using new drug delivery ...
ADELAIDE, Australia--(BUSINESS WIRE)--Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a global, clinical stage biopharmaceutical company, announces that an additional data analysis conducted in Sweden by ...
ADELAIDE, Australia, July 6, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQB:BNOEF) (Bionomics or Company), a global, clinical stage biopharmaceutical company, is pleased to announce that it ...
BNC210 novel oral tablet formulation (900 mg given twice daily) exceeds blood exposure projected for upcoming Phase 2b PTSD trialBNC210 Phase 2b PTSD trial on target for start in mid-2021 with final ...
STEVENSON, Wash., Feb. 3, 2011 (GLOBE NEWSWIRE) -- Total Nutraceutical Solutions, Inc. (TNS) (OTCBB:TNUS), announced today that TNS has formulated Ergo-D Traum™, a proprietary mushroom-phytonutrient ...
Treatment with TSND-201 was associated with statistically significant improvement in PTSD symptoms. The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 ...
Just as global security is starting to look a bit precarious, Tonix Pharmaceuticals has started recruiting military personnel into a phase 3 trial of its drug candidate for combat-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback